SCHEMBL17028058

SCHEMBL17028058

O=C(Nc1ncccn1)c1ccccn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 2/20 0.61
▸ HDAC3 O15379 1/20 0.61
▸ HDAC4 P56524 1/20 0.61
▸ HDAC1 Q13547 1/20 0.61
▸ HDAC7 Q8WUI4 1/20 0.61
▸ HDAC2 Q92769 1/20 0.61
▸ HDAC10 Q969S8 1/20 0.61
▸ HDAC11 Q96DB2 1/20 0.61
▸ HDAC8 Q9BY41 1/20 0.61
▸ HDAC9 Q9UKV0 1/20 0.61
▸ HDAC5 Q9UQL6 1/20 0.61
▸ CES2 O00748 1/20 0.59
▸ CES1 P23141 1/20 0.59
▸ NPC1 O15118 3/20 0.59
▸ RAB9A P51151 3/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.59
▸ LMNA P02545 2/20 0.59
▸ L3MBTL1 Q9Y468 2/20 0.59
▸ METAP2 P50579 1/20 0.59
▸ METAP1 P53582 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989152 0.83 HDAC1 (0.77) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL23406114 0.83 GRM5 (0.54) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL29744091 0.83 GRM5 (0.54) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL1147702 0.83 KDM4E (0.73) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL4508472 0.83 CES2 (0.64) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL231897 0.82 KDR (0.78) HDAC6NPC1RAB9ASMN1; SMN2GRM4
SCHEMBL4522324 0.82 HDAC1 (0.69) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL9384187 0.82 NPC1 (0.72) NPC1RAB9ASMN1; SMN2L3MBTL1MAPT
SCHEMBL11223392 0.81 CES2 (0.61) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL1422257 0.81 CES2 (0.61) HDAC6HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3107898-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS Takeda Pharmaceutical Company Limited (JP) 2016-12-28 — — EP claimed
WO-2015124932-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS TAKEDA CAMBRIDGE LIMITED (GB) 2015-08-27 — — WO claimed
CN-110590749-B Crystal form of pyridylamino pyrimidine derivative mesylate, preparation and application thereof 上海艾力斯医药科技股份有限公司 2020-11-06 — — CN disclosed
EP-3107898-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS Takeda Pharmaceutical Company Limited (JP) 2016-12-28 — — EP disclosed
WO-2016015453-A1 PYRIDINE AMIDOPYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF 上海艾力斯医药科技有限公司 2016-02-04 — — WO disclosed
WO-2015124932-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS TAKEDA CAMBRIDGE LIMITED (GB) 2015-08-27 — — WO disclosed
Send feedback